Clinical Trial Update: An Open-Label, Single Arm Study of the Efficacy of Accelerated Intermittent Theta Burst Stimulation in Schizophrenia Patients With Persistent Negative Symptoms [Phase 3]

View source ↗

Summary

A Phase 3 open-label, single-arm trial assessing accelerated intermittent theta burst stimulation for persistent negative symptoms in schizophrenia is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Accelerated Intermittent Theta Burst Stimulation

Snippet

Sponsor: Institute of Mental Health, Singapore | Conditions: Schizophrenia; Negative Type | Phase 3 | Status: RECRUITING